These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 24918359)

  • 1. Designing vaccines to neutralize effective toxin delivery by enterotoxigenic Escherichia coli.
    Fleckenstein JM; Sheikh A
    Toxins (Basel); 2014 Jun; 6(6):1799-812. PubMed ID: 24918359
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enterotoxigenic Escherichia coli Adhesin-Toxoid Multiepitope Fusion Antigen CFA/I/II/IV-3xSTa
    Nandre R; Ruan X; Lu T; Duan Q; Sack D; Zhang W
    Infect Immun; 2018 Mar; 86(3):. PubMed ID: 29263112
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Review on pathogenicity mechanism of enterotoxigenic Escherichia coli and vaccines against it.
    Mirhoseini A; Amani J; Nazarian S
    Microb Pathog; 2018 Apr; 117():162-169. PubMed ID: 29474827
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Progress and hurdles in the development of vaccines against enterotoxigenic Escherichia coli in humans.
    Zhang W; Sack DA
    Expert Rev Vaccines; 2012 Jun; 11(6):677-94. PubMed ID: 22873126
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mapping the Neutralizing Epitopes of Enterotoxigenic Escherichia coli K88 (F4) Fimbrial Adhesin and Major Subunit FaeG.
    Lu T; Moxley RA; Zhang W
    Appl Environ Microbiol; 2019 Jun; 85(11):. PubMed ID: 30926730
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel antigens for enterotoxigenic Escherichia coli vaccines.
    Fleckenstein J; Sheikh A; Qadri F
    Expert Rev Vaccines; 2014 May; 13(5):631-9. PubMed ID: 24702311
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Examples for vaccines against diarrheal diseases--rotavirus and traveller's diarrhea].
    Kollaritsch H; Wiedermann U
    Wien Med Wochenschr; 2007; 157(5-6):102-6. PubMed ID: 17427005
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunizations with Enterotoxigenic Escherichia coli Heat-Stable Toxin Conjugates Engender Toxin-Neutralizing Antibodies in Mice That Also Cross-React with Guanylin and Uroguanylin.
    Diaz Y; Govasli ML; Zegeye ED; Sommerfelt H; Steinsland H; Puntervoll P
    Infect Immun; 2019 Jul; 87(7):. PubMed ID: 31061144
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neutralizing Anti-Heat-Stable Toxin (STa) Antibodies Derived from Enterotoxigenic Escherichia coli Toxoid Fusions with STa Proteins Containing N12S, L9A/N12S, or N12S/A14T Mutations Show Little Cross-Reactivity with Guanylin or Uroguanylin.
    Duan Q; Huang J; Xiao N; Seo H; Zhang W
    Appl Environ Microbiol; 2018 Jan; 84(2):. PubMed ID: 29079628
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Emerging Themes in the Molecular Pathogenesis of Enterotoxigenic Escherichia coli.
    Fleckenstein JM; Sheikh A
    J Infect Dis; 2021 Dec; 224(12 Suppl 2):S813-S820. PubMed ID: 34273153
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular mechanisms of enterotoxigenic Escherichia coli infection.
    Fleckenstein JM; Hardwidge PR; Munson GP; Rasko DA; Sommerfelt H; Steinsland H
    Microbes Infect; 2010 Feb; 12(2):89-98. PubMed ID: 19883790
    [TBL] [Abstract][Full Text] [Related]  

  • 12. WHO consultation on ETEC and Shigella burden of disease, Geneva, 6-7th April 2017: Meeting report.
    Hosangadi D; Smith PG; Kaslow DC; Giersing BK;
    Vaccine; 2019 Nov; 37(50):7381-7390. PubMed ID: 29352598
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Advances in new vaccines against human enterotoxigenic Escherichia coli--A review].
    Xia P; Meng X; Zhu G
    Wei Sheng Wu Xue Bao; 2016 Feb; 56(2):198-208. PubMed ID: 27373068
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Directed evaluation of enterotoxigenic Escherichia coli autotransporter proteins as putative vaccine candidates.
    Harris JA; Roy K; Woo-Rasberry V; Hamilton DJ; Kansal R; Qadri F; Fleckenstein JM
    PLoS Negl Trop Dis; 2011 Dec; 5(12):e1428. PubMed ID: 22163060
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enterotoxigenic
    Crofts AA; Giovanetti SM; Rubin EJ; Poly FM; Gutiérrez RL; Talaat KR; Porter CK; Riddle MS; DeNearing B; Brubaker J; Maciel M; Alcala AN; Chakraborty S; Prouty MG; Savarino SJ; Davies BW; Trent MS
    Proc Natl Acad Sci U S A; 2018 Sep; 115(38):E8968-E8976. PubMed ID: 30126994
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Overcoming Enterotoxigenic Escherichia coli Pathogen Diversity: Translational Molecular Approaches to Inform Vaccine Design.
    Fleckenstein JM; Rasko DA
    Methods Mol Biol; 2016; 1403():363-83. PubMed ID: 27076141
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Strategies to overexpress enterotoxigenic Escherichia coli (ETEC) colonization factors for the construction of oral whole-cell inactivated ETEC vaccine candidates.
    Tobias J; Svennerholm AM
    Appl Microbiol Biotechnol; 2012 Mar; 93(6):2291-300. PubMed ID: 22350259
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunization with the MipA, Skp, or ETEC_2479 Antigens Confers Protection against Enterotoxigenic
    Hays MP; Kumar A; Martinez-Becerra FJ; Hardwidge PR
    Front Cell Infect Microbiol; 2016; 6():181. PubMed ID: 28018863
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vaccines against traveler's diarrhoea and rotavirus disease - a review.
    Wiedermann U; Kollaritsch H
    Wien Klin Wochenschr; 2006; 118(19-20 Suppl 3):2-8. PubMed ID: 17131234
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Application of a Novel Epitope- and Structure-Based Vaccinology-Assisted Fimbria-Toxin Multiepitope Fusion Antigen of Enterotoxigenic Escherichia coli for Development of Multivalent Vaccines against Porcine Postweaning Diarrhea.
    Lu T; Moxley RA; Zhang W
    Appl Environ Microbiol; 2020 Nov; 86(24):. PubMed ID: 32144103
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.